Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Sanofi    crawled date : 2021 - 10 - 21    save search

John King is recognized by Continental Who's Who
Published: 2021-10-21 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -1.1% H: 0.0% C: -0.41%
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.41% H: 0.0% C: 0.0%


Ligand and CR Double-Crane Enter Collaboration Agreement to Develop an Oral COVID-19 Therapeutic Using Ligand’s BEPro Technology™
Published: 2021-10-21 (Crawled : 14:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.41% C: 0.41%
LGND | $68.58 -5.37% -5.67% 250K twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 1.8% C: 0.91%

covid collaboration technology
ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million
Published: 2021-10-21 (Crawled : 13:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.41% C: 0.41%


ReCode Scores $80 Million to Advance mRNA-Based Cystic Fibrosis, PCD Programs
Published: 2021-10-21 (Crawled : 13:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.41% C: 0.41%

fibrosis cystic fibrosis
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine
Published: 2021-10-21 (Crawled : 11:00) - globenewswire.com
PFE | News A | $26.26 1.0% -0.08% 36M twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 0.08% C: -0.45%
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.41% C: 0.41%
BNTX | News | $88.01 1.38% 1.36% 390K twitter stocktwits trandingview |
Health Technology
| | O: 2.66% H: 3.69% C: 3.53%

covid vaccine phase 3 trial
Oncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates
Published: 2021-10-21 (Crawled : 09:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.41% C: 0.41%

fibrosis collaboration drug
Gainers vs Losers
75% 25%

Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M twitter stocktwits trandingview |

AGBA | $2.565 105.2% 51.27% 200M twitter stocktwits trandingview |
Finance

MLEC | $2.44 74.29% 42.62% 78M twitter stocktwits trandingview |
n/a

EDBL | News | $6.28 67.02% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.91 48.81% 32.8% 180K twitter stocktwits trandingview |

ZAPP | $0.2175 47.16% 32.05% 16M twitter stocktwits trandingview |
n/a

ONFO | $0.6075 38.38% 27.74% 7.3M twitter stocktwits trandingview |
n/a

VIVK | $1.48 38.32% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.8M twitter stocktwits trandingview |

SDIG A | $3.635 35.13% 26.0% 1M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.